SPDR S&P Pharmaceuticals ETF
XPH
XPH
81 hedge funds and large institutions have $127M invested in SPDR S&P Pharmaceuticals ETF in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $143M → $127M (-$16.2M)
Holders
81
Holding in Top 10
–
Calls
$225K
Puts
–
Top Buyers
| 1 | +$1.42M | |
| 2 | +$1.12M | |
| 3 | +$734K | |
| 4 |
LPL Financial
San Diego,
California
|
+$317K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$305K |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$1.54M | |
| 3 | -$1.11M | |
| 4 |
Morgan Stanley
New York
|
-$860K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$736K |